BMJ UK BMJ Americas BMJ Brazil BMJ China BMJ India

As a researcher, publishing your work is an important step in enhancing your academic career and ensuring your work has a wider impact. At BMJ, we are with you at every step of your publication journey and at any stage of your career. We can help you to optimise the presentation and impact of your work, and to disseminate your findings to the people who need to read it.

Publishing in one of our fully open access or transformative journals complies with policies set by funders (including Plan S), institutions and governments.

Options to publish your research open access:

Fully open access journals Transformative journals    Hybrid  journals                        The  BMJ                                    

Explore our journals in rheumatology







Acceptance rate: 32%

Time to first decision:                  31 days

Citescore: 7.1

Journal Impact Factor:      5.806

JIF Rank (Rheumatology):  7/34

Acceptance rate: 40%

Time to first decision:                  32 days

Citescore: 5.6

Journal Impact Factor:      4.687

JIF Rank (Rheumatology): 16/34 

Acceptance rate: 15%

Time to first decision:                  29 days

Citescore: 28.5

Journal Impact Factor:      28.003

JIF Rank (Rheumatology): 3/34 

Acceptance rate: 47%

Time to first decision* :              6 days

Citescore: 3.9

Journal Impact Factor:      3.007

JIF Rank (Medicine, General & Internal): 86/172

*without review

 Launched in 2022




Citescore: 10.2

Journal Impact Factor:      96.216

JIF Rank (Medicine, General & Internal): 4/172

Rheumatology: 2022 open access highlights

Most read open access articles published in 2022:

Our open access content received on average 7 times more views than other content.


Top mentioned open access articles published in 2022:

Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking



Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study



Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs



Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis


Ready to get started with your paper?

Resources for every stage of your publishing journey with BMJ

Before you submit Preparing your paper After submission Promoting your paper

Introducing our latest open access journals


BMJ Mental Health (formerly Evidence-Based Mental Health) is an open access journal supporting mental health researchers and practitioners in improving patient and carer outcomes. The journal facilitates multidisciplinary collaboration among psychiatrists, psychologists and other mental health professionals, encourages debate on clinically relevant topics, and informs real world practice.  


BMJ Oncology is an open access, peer-reviewed journal publishing across the broad spectrum of cancer research, investigation, treatment and practice. Its mission is to optimise cancer care and improve patient outcomes. The journal prioritises high quality original research and review papers across the broad spectrum of cancer research, investigation, treatment and practice.



Launching April 2023

BMJ Public Health is an open access, peer-reviewed journal covering all aspects of public health, from global issues such as the impact of climate change on population health, to studies conducted at a local level.

Sign up to receive eAlerts

Stay up to date with the latest research in rheumatology

      Sign up to receive eAlerts



Contact us

For general queries, please contact our customer services team
We will respond to any online and email queries as soon as possible